Interferon at the crossroads of allergy and viral infections

Journal of Leukocyte Biology

Volumn 98, Issue 2, 2015, Pages 185-194

  Gonzales van Horn, Sarah R ^a   David Farrar, J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atopic asthma; Atopic disease; IgE mediated regulation; Th2 cell regulation

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN E; INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; SUPPRESSOR OF CYTOKINE SIGNALING 1; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA 3; GATA3 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ALLERGY; ATOPY; CD4+ T LYMPHOCYTE; GOBLET CELL; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; LUNG ALVEOLUS EPITHELIUM; MORAXELLACEAE INFECTION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RHINOVIRUS INFECTION; STREPTOCOCCUS PNEUMONIA; UPPER RESPIRATORY TRACT; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IMMUNITY; VIRUS INFECTION; ANTAGONISTS AND INHIBITORS; B LYMPHOCYTE; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; GRANULOCYTE; HYPERSENSITIVITY; IMMUNOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; TH2 CELL; VIROLOGY; VIRUS DISEASES;

HEPATITIS C VIRUS;

B-LYMPHOCYTES; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GRANULOCYTES; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN E; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN-4; SIGNAL TRANSDUCTION; TH2 CELLS; VIRUS DISEASES;

EID: 84938324819     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RU0315-099R     Document Type: Review

References (103)

1. Salaman, R. N. (1933) Protective inoculation against a plant virus. Nature 131, 468
2. Isaacs, A., Lindenmann, J. (1957) Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147, 258–267
3. Platanias, L. C. (2005) Mechanisms of type-I- and type-II-interferonmediated signalling. Nat. Rev. Immunol. 5, 375–386
4. Sadler, A. J., Williams, B. R. G. (2008) Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559–568
5. Huber, J. P., Farrar, J. D. (2011) Regulation of effector and memory T-cell functions by type I interferon. Immunology 132, 466–474
6. Stark, G. R., Kerr, I.M., Williams, B. R. G., Silverman, R.H., Schreiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264
7. Freeman, J., Baglino, S., Friborg, J., Kraft, Z., Gray, T., Hill, M., McPhee, F., Hillson, J., Lopez-Talavera, J. C., Wind-Rotolo, M. (2014) Pegylated interferons lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells. J. Viral Hepat. 21, e1–e9
8. Liu, Y.-J. (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275–306
9. Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., Donnelly, R. P. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69–77
10. Witte, K., Gruetz, G., Volk, H.-D., Looman, A. C., Asadullah, K., Sterry, W., Sabat, R., Wolk, K. (2009) Despite IFN-l receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 10, 702–714
11. Dai, J., Megjugorac, N. J., Gallagher, G. E., Yu, R. Y. L., Gallagher, G. (2009) IFN-l1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood 113, 5829–5838
12. Boehm, U., Klamp, T., Groot, M., Howard, J. C. (1997) Cellular responses to interferon-g. Annu. Rev. Immunol. 15, 749–795
13. Lack, G., Renz, H., Saloga, J., Bradley, K. L., Loader, J., Leung, D. Y., Larsen, G., Gelfand, E. W. (1994) Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J. Immunol. 152, 2546–2554
14. Boguniewicz, M., Schneider, L. C., Milgrom, H., Newell, D., Kelly, N., Tam, P., Izu, A. E., Jaffe, H. S., Bucalo, L. R., Leung, D. Y. M. (1993) Treatment of steroid-dependent asthma with recombinant interferongamma. Clin. Exp. Allergy 23, 785–790
15. Papadopoulos, N. G., Stanciu, L. A., Papi, A., Holgate, S. T., Johnston, S. L. (2002) A defective type 1 response to rhinovirus in atopic asthma. Thorax 57, 328–332
16. Campbell, D. E., Fryga, A. S., Bol, S., Kemp, A. S. (1999) Intracellular interferon-gamma (IFN-gamma) production in normal children and children with atopic dermatitis. Clin. Exp. Immunol. 115, 377–382
17. World Health Organization. (2013) Asthma Fact Sheet No. 307. http://www.who.int/mediacentre/factsheets/fs307/en/.
18. Novak, N., Bieber, T. (2003) Allergic and nonallergic forms of atopic diseases. J. Allergy Clin. Immunol. 112, 252–262
19. Su, Z., Lin, J., Lu, F., Zhang, X., Zhang, L., Gandhi, N. B., de Paiva, C. S., Pflugfelder, S. C., Li, D.-Q. (2013) Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation. Mucosal Immunol. 6, 921–930
20. Junttila, I. S., Watson, C. J., Kummola, L., Chen, X., Hu-Li, J., Guo, L., Yagi, R., Paul, W. E. (2013) Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3. J. Allergy Clin. Immunol. 132, 704–712.e10
21. Gregory, L. G., Jones, C. P., Walker, S. A., Sawant, D., Gowers, K. H. C., Campbell, G. A., McKenzie, A. N. J., Lloyd, C. M. (2013) IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 68, 82–90
22. Wills-Karp, M. (2004) Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202, 175–190
23. Lewis, C. C., Aronow, B., Hutton, J., Santeliz, J., Dienger, K., Herman, N., Finkelman, F. D., Wills-Karp, M. (2009) Unique and overlapping gene expression patterns driven by IL-4 and IL-13 in the mouse lung. J. Allergy Clin. Immunol. 123, 795–804.e8
24. Novak, N., Kraft, S., Bieber, T. (2001) IgE receptors. Curr. Opin. Immunol. 13, 721–726
25. Gilfillan, A. M., Tkaczyk, C. (2006) Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6, 218–230
26. Schwartz, L. B., Austen, K. F. (1980) Enzymes of the mast cell granule. J. Invest. Dermatol. 74, 349–353
27. Fahy, J. V., Dickey, B. F. (2010) Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233–2247
28. Swain, S. L., Weinberg, A. D., English, M., Huston, G. (1990) IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145, 3796–3806
29. Zheng, W., Flavell, R. A. (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596
30. Kuhl, K., Hanania, N. A. (2012) Targeting IgE in asthma. Curr. Opin. Pulm. Med. 18, 1–5
31. Chang, H.-C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A.-N., Han, L., Nguyen, E. T., Robertson, M. J., Perumal, N. B., Tepper, R. S., Nutt, S. L., Kaplan, M. H. (2010) The transcription factor PU.1 is required for the development of IL-9- producing T cells and allergic inflammation. Nat. Immunol. 11, 527–534
32. Temann, U.-A., Laouar, Y., Eynon, E. E., Homer, R., Flavell, R. A. (2007) IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 19, 1–10
33. Steenwinckel, V., Louahed, J., Orabona, C., Huaux, F., Warnier, G., McKenzie, A., Lison, D., Levitt, R., Renauld, J. C. (2007) IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J. Immunol. 178, 3244–3251
34. Cooper, P. J., Barreto, M. L., Rodrigues, L. C. (2006) Human allergy and geohelminth infections: a review of the literature and a proposed conceptual model to guide the investigation of possible causal associations. Br. Med. Bull. 79-80, 203–218
35. Strachan, D. P. (1989) Hay fever, hygiene, and household size. BMJ 299, 1259–1260
36. Lynch, S. V., Wood, R. A., Boushey, H., Bacharier, L. B., Bloomberg, G. R., Kattan, M., O’Connor, G. T., Sandel, M. T., Calatroni, A., Matsui, E., Johnson, C. C., Lynn, H., Visness, C. M., Jaffee, K. F., Gergen, P. J., Gold, D. R., Wright, R. J., Fujimura, K., Rauch, M., Busse, W. W., Gern, J. E. (2014) Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J. Allergy Clin. Immunol. 134, 593–601.e12
37. Bals, R. (2000) Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 1, 141–150
38. Gern, J. E., Busse, W. W. (1999) Association of rhinovirus infections with asthma. Clin. Microbiol. Rev. 12, 9–18
39. Gavala, M. L., Bertics, P. J., Gern, J. E. (2011) Rhinoviruses, allergic inflammation, and asthma. Immunol. Rev. 242, 69–90
40. Rowe, R. K., Gill, M. A. (2015) Asthma: the interplay between viral infections and allergic diseases. Immunol. Allergy Clin. North Am. 35, 115–127
41. Uller, L., Leino, M., Bedke, N., Sammut, D., Green, B., Lau, L., Howarth, P. H., Holgate, S. T., Davies, D. E. (2010) Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax 65, 626–632
42. Kato, A., Favoreto, Jr., S., Avila, P. C., Schleimer, R. P. (2007) TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J. Immunol. 179, 1080–1087
43. Gern, J. E., Busse, W. W. (2002) Relationship of viral infections to wheezing illnesses and asthma. Nat. Rev. Immunol. 2, 132–138
44. Woś, M., Sanak, M., Soja, J., Olechnowicz, H., Busse, W. W., Szczeklik, A. (2008) The presence of rhinovirus in lower airways of patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 177, 1082–1089
45. Gern, J. E. (2015) How rhinovirus infections cause exacerbations of asthma. Clin. Exp. Allergy 45, 32–42
46. Short, K. R., Reading, P. C., Brown, L. E., Pedersen, J., Gilbertson, B., Job, E. R., Edenborough, K. M., Habets, M. N., Zomer, A., Hermans, P. W. M., Diavatopoulos, D. A., Wijburg, O. L. (2013) Influenza-induced inflammation drives pneumococcal otitis media. Infect. Immun. 81, 645–652
47. McCullers, J. A. (2006) Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571–582
48. Bosch, A. A., Biesbroek, G., Trzcinski, K., Sanders, E. A., Bogaert, D. (2013) Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 9, e1003057
49. Kloepfer, K. M., Lee, W. M., Pappas, T. E., Kang, T. J., Vrtis, R. F., Evans, M. D., Gangnon, R. E., Bochkov, Y. A., Jackson, D. J., Lemanske, R. F., Gern, J. E. (2014) Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J. Allergy Clin. Immunol. 133, 1301–1307.e3
50. Heilmann, C. (2011) Adhesion mechanisms of staphylococci. In Bacterial Adhesion. (D. Linke, A. Goldman, eds.), Springer, Netherlands, 105–123
51. Sun, K., Metzger, D. W. (2008) Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat. Med. 14, 558–564
52. Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., Deng, J. C. (2009) Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910–1920
53. Hayden, F. G., Kaiser, D. L., Albrecht, J. K. (1988) Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. Antimicrob. Agents Chemother. 32, 224–230
54. Yin, Z., Dai, J., Deng, J., Sheikh, F., Natalia, M., Shih, T., Lewis-Antes, A., Amrute, S. B., Garrigues, U., Doyle, S., Donnelly, R. P., Kotenko, S. V., Fitzgerald-Bocarsly, P. (2012) Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J. Immunol. 189, 2735–2745
55. Khaitov, M. R., Laza-Stanca, V., Edwards, M. R., Walton, R. P., Rohde, G., Contoli, M., Papi, A., Stanciu, L. A., Kotenko, S. V., Johnston, S. L. (2009) Respiratory virus induction of alpha-, beta- and lambdainterferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64, 375–386
56. Gill, M. A., Bajwa, G., George, T. A., Dong, C. C., Dougherty, I. I., Jiang, N., Gan, V. N., Gruchalla, R. S. (2010) Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J. Immunol. 184, 5999–6006
57. Durrani, S. R., Montville, D. J., Pratt, A. S., Sahu, S., DeVries, M. K., Rajamanickam, V., Gangnon, R. E., Gill, M. A., Gern, J. E., Lemanske, Jr., R. F., Jackson, D. J. (2012) Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J. Allergy Clin. Immunol. 130, 489–495
58. Sykes, A., Edwards, M. R., Macintyre, J., del Rosario, A., Bakhsoliani, E., Trujillo-Torralbo, M.-B., Kon, O. M., Mallia, P., McHale, M., Johnston, S. L. (2012) Rhinovirus 16-induced IFN-a and IFN-b are deficient in bronchoalveolar lavage cells in asthmatic patients. J. Allergy Clin. Immunol. 129, 1506–1514.e6
59. Wark, P. A. B., Johnston, S. L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., Holgate, S. T., Davies, D. E. (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937–947
60. Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., Slater, L., Lewis-Antes, A., Kon, O. M., Holgate, S. T., Davies, D. E., Kotenko, S. V., Papi, A., Johnston, S. L. (2006) Role of deficient type III interferon-l production in asthma exacerbations. Nat. Med. 12, 1023–1026
61. Bochkov, Y. A., Hanson, K. M., Keles, S., Brockman-Schneider, R. A., Jarjour, N. N., Gern, J. E. (2010) Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 3, 69–80
62. Lopez-Souza, N., Favoreto, S., Wong, H., Ward, T., Yagi, S., Schnurr, D., Finkbeiner, W. E., Dolganov, G. M., Widdicombe, J. H., Boushey, H. A., Avila, P. C. (2009) In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol. 123, 1384–1390.e2
63. Parsons, K. S., Hsu, A. C., Wark, P. A. B. (2014) TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection. Clin. Exp. Allergy 44, 91–101
64. Roponen, M., Yerkovich, S. T., Hollams, E., Sly, P. D., Holt, P. G., Upham, J. W. (2010) Toll-like receptor 7 function is reduced in adolescents with asthma. Eur. Respir. J. 35, 64–71
65. Pritchard, A. L., White, O. J., Burel, J. G., Carroll, M. L., Phipps, S., Upham, J. W. (2014) Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE 9, e106501
66. Gielen, V., Sykes, A., Zhu, J., Chan, B., Macintyre, J., Regamey, N., Kieninger, E., Gupta, A., Shoemark, A., Bossley, C., Davies, J., Saglani, S., Walker, P., Nicholson, S. E., Dalpke, A. H., Kon, O. M., Bush, A., Johnston, S. L., Edwards, M. R. (2015) Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons. J. Allergy Clin. Immunol. doi:/10.1016/j.jaci.2014.11.039 [Epub ahead of print].
67. Mazzoni, A., Leifer, C. A., Mullen, G. E. D., Kennedy, M. N., Klinman, D. M., Segal, D. M. (2003) Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J. Immunol. 170, 2269–2273
68. Geijtenbeek, T. B. H., Gringhuis, S. I. (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465–479
69. Barrett, N. A., Maekawa, A., Rahman, O. M., Austen, K. F., Kanaoka, Y. (2009) Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J. Immunol. 182, 1119–1128
70. Dahlén, S. E., Hedqvist, P., Hammarström, S., Samuelsson, B. (1980) Leukotrienes are potent constrictors of human bronchi. Nature 288, 484–486
71. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y., Schmitz, J. (2001) BDCA-2, a novel plasmacytoid dendritic cell-specific type II Ctype lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194, 1823–1834
72. Shreffler, W. G., Castro, R. R., Kucuk, Z. Y., Charlop-Powers, Z., Grishina, G., Yoo, S., Burks, A. W., Sampson, H. A. (2006) The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol. 177, 3677–3685
73. Pritchard, A. L., Carroll, M. L., Burel, J. G., White, O. J., Phipps, S., Upham, J. W. (2012) Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mechanism with relevance to asthma. J. Immunol. 188, 5898–5905
74. Schandené, L., Del Prete, G. F., Cogan, E., Stordeur, P., Crusiaux, A., Kennes, B., Romagnani, S., Goldman, M. (1996) Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J. Clin. Invest. 97, 309–315
75. Shibuya, H., Hirohata, S. (2005) Differential effects of IFN-a on the expression of various TH2 cytokines in human CD4+ T cells. J. Allergy Clin. Immunol. 116, 205–212
76. Wenner, C. A., Güler, M. L., Macatonia, S. E., O’Garra, A., Murphy, K. M. (1996) Roles of IFN-g and IFN-a in IL-12-induced T helper cell-1 development. J. Immunol. 156, 1442–1447
77. Huber, J. P., Ramos, H. J., Gill, M. A., Farrar, J. D. (2010) Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J. Immunol. 185, 813–817
78. Jordan, W. J., Eskdale, J., Srinivas, S., Pekarek, V., Kelner, D., Rodia, M., Gallagher, G. (2007) Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun. 8, 254–261
79. Huber, J. P., Gonzales-van Horn, S. R., Roybal, K. T., Gill, M. A., Farrar, J. D. (2014) IFN-a suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells. J. Immunol. 192, 5687–5694
80. Aldebert, D., Lamkhioued, B., Desaint, C., Gounni, A. S., Goldman, M., Capron, A., Prin, L., Capron, M. (1996) Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. Blood 87, 2354–2360
81. Chen, Y.-H., Bieneman, A. P., Creticos, P. S., Chichester, K. L., Schroeder, J. T. (2003) IFN-a inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release. J. Allergy Clin. Immunol. 112, 944–950
82. Péne, J., Rousset, F., Briére, F., Chrétien, I., Bonnefoy, J. Y., Spits, H., Yokota, T., Arai, N., Arai, K., Banchereau, J. (1988) IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85, 6880–6884
83. Finkelman, F. D., Svetic, A., Gresser, I., Snapper, C., Holmes, J., Trotta, P. P., Katona, I. M., Gause, W. C. (1991) Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J. Exp. Med. 174, 1179–1188
84. Moschen, A. R., Geiger, S., Krehan, I., Kaser, A., Tilg, H. (2008) Interferon-alpha controls IL-17 expression in vitro and in vivo. Immunobiology 213, 779–787
85. Ramgolam, V. S., Sha, Y., Jin, J., Zhang, X., Markovic-Plese, S. (2009) IFNb inhibits human Th17 cell differentiation. J. Immunol. 183, 5418–5427
86. Simon, H.-U., Seelbach, H., Ehmann, R., Schmitz, M. (2003) Clinical and immunological effects of low-dose IFN-a treatment in patients with corticosteroid-resistant asthma. Allergy 58, 1250–1255
87. Kroegel, C., Bergmann, N., Foerster, M., Workalemahu, G., Machnik, A., Mock, B., Reissig, A. (2006) Interferon-alphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Effect on disease control and systemic glucocorticosteroid dose. Respiration 73, 566–570
88. Gratzl, S., Palca, A., Schmitz, M., Simon, H.-U. (2000) Treatment with IFN-alpha in corticosteroid-unresponsive asthma. J. Allergy Clin. Immunol. 105, 1035–1036
89. Zielinski, R. M., Lawrence, W. D. (1990) Interferon-a for the hypereosinophilic syndrome. Ann. Intern. Med. 113, 716–718
90. Butterfield, J. H., Gleich, G. J. (1994) Interferon-a treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann. Intern. Med. 121, 648–653
91. Tatsis, E., Schnabel, A., Gross, W. L. (1998) Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann. Intern. Med. 129, 370–374
92. Kanazawa, H., Mamoto, T., Hirata, K., Yoshikawa, J. (2003) Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection: a preliminary study. Chest 123, 600–603
93. Kroegel, C., Bergmann, N., Heider, C., Moeser, A., Happe, J., Schlenker, Y., Bartuschka, B., Henzgen, M., Walther, R., Reissig, A., Foerster, M. (2009) [Interferon-alpha as treatment option in severe persistent uncontrolled bronchial asthma: an open label study]. Pneumologie 63, 307–313
94. Metzler, C., Schnabel, A., Gross, W. L., Hellmich, B. (2008) A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome. Clin. Exp. Rheumatol. 26 (3 Suppl 49) S35–S40
95. Butterfield, J. H., Weiler, C. R. (2012) Use of pegylated interferon in hypereosinophilic syndrome. Leuk. Res. 36, 192–197
96. Seeliger, B., Foerster, M., Neumann, T., Moeser, A., Happe, J., Kehler, N., Kroegel, C. (2013) Interferon-a induced remission in three patients with eosinophilic granulomatosis and polyangiitis. A case study. Respir. Med. Case Rep. 10, 60–63
97. Djukanović, R., Harrison, T., Johnston, S. L., Gabbay, F., Wark, P., Thomson, N. C., Niven, R., Singh, D., Reddel, H. K., Davies, D. E., Marsden, R., Boxall, C., Dudley, S., Plagnol, V., Holgate, S. T., Monk, P.; INTERCIA Study Group. (2014) The effect of inhaled interferon-b on worsening of asthma symptoms caused by viral infections. A randomized trial. Am. J. Respir. Crit. Care Med. 190, 145–154
98. Yamamoto, N., Murata, K., Nakano, T. (2005) Remission of bronchial asthma after viral clearance in chronic hepatitis C. World J. Gastroenterol. 11, 7545–7546
99. Cacopardo, B., Rita Pinzone, M., Palermo, F., Nunnari, G. (2012) Changes in serum interleukin-33 concentration before and after treatment with pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C genotype 1b infection. Hepat. Mon. 12, e7611
100. Humbert, M., Busse, W., Hanania, N. A., Lowe, P. J., Canvin, J., Erpenbeck, V. J., Holgate, S. (2014) Omalizumab in asthma: an update on recent developments. J. Allergy Clin. Immunol. Pract. 2, 525–536.e1
101. Ramírez, F., Fowell, D. J., Puklavec, M., Simmonds, S., Mason, D. (1996) Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156, 2406–2412
102. Blotta, M. H., DeKruyff, R. H., Umetsu, D. T. (1997) Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158, 5589–5595
103. Almawi, W. Y., Melemedjian, O. K., Rieder, M. J. (1999) An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin. Transplant. 13, 365–374.